Benefit of antibiotic therapy on pouchitis after ileal pouch anal anastomosis: A systematic review and meta-analysis of clinical trials

Central European Journal of Medicine

Volumn 4, Issue 2, 2009, Pages 164-170

  Elahi, Behzad ^a   Nikfar, Shekoufeh ^b   Derakhshani, Saeed ^c   Vafaie, Mohammad ^c   Abdollahi, Mohammad ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c Baharan Coloproctology Surgical Clinic Tehran   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic; Ileal pouch anal anastomosis; Meta analysis; Pouchitis

Indexed keywords

BUDESONIDE; CIPROFLOXACIN; ENEMA; METRONIDAZOLE; RIFAXIMIN; TINIDAZOLE;

ANTIBIOTIC THERAPY; ARTICLE; BEDTIME DOSAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ACTIVITY; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; MEDICAL LITERATURE; META ANALYSIS; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 70349571195     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-009-0019-4     Document Type: Article

References (50)

1. V.E. Pricolo 1994 Ileal pouch-anal anastomosis: the ideal operation for ulcerative colitis and adenomatous polyposis coli? R. I. Med. 77 382 384 7812055 1:STN:280:ByqC3M7hvFI%3D
2. D. Blumberg D.E. Beck 2002 Surgery for ulcerative colitis, Gastroenterol Clin. North Am. 31 219 235
3. O. Aziz T. Athanasiou V.W. Fazio R.J. Nicholls A.W. Darzi J. Church, et al. 2006 Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis Br. J. Surg. 93 407 417 16511903 10.1002/bjs.5276 1:STN:280:DC%2BD287nsFCqug%3D%3D
4. M.R. Keighley 1996 Review article: the management of pouchitis Aliment. Pharmacol. Ther. 10 449 457 8853749 10.1046/j.1365-2036.1996.32174000.x 1:STN:280:ByiD3cnksFI%3D
5. R.J. Nicholls P. Belliveau M. Neill M. Wilks S. Tabaqchali 1981 Restorative proctocolectomy with ileal reservoir: a pathophysiological assessment Gut 22 462 468 7262623 10.1136/gut.22.6.462 1:STN:280: DyaL3M3mt1SntQ%3D%3D
6. G. Zuccaro Jr. V.W. Fazio J.M. Church I.C. Lavery W.B. Ruderman R.G. Farmer 1989 Pouch ileitis Dig. Dis. Sci. 34 1505 1510 2791801 10.1007/BF01537101
7. G.N. Tytgat S.J. van Deventer 1988 Pouchitis Int. J. Colorectal Dis. 3 226 228 3058838 10.1007/BF01660720 1:STN:280:BiaD28jntVU%3D (Pubitemid 19000964)
8. E.J. Simchuk R.C. Thirlby 2000 Risk factors and true incidence of pouchitis in patients after ileal pouchanal anastomoses World J. Surg. 24 851 856 10833254 10.1007/s002680010136 1:STN:280:DC%2BD3c3ptlCqtQ%3D%3D (Pubitemid 30437484)
9. W.A. Kmiot D. Youngs R. Tudor H. Thompson M.R. Keighley 1993 Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis Br. J. Surg. 80 1445 1449 8252361 10.1002/bjs.1800801132 1:STN:280:ByuD2szms1M%3D (Pubitemid 23345115)
10. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2006 A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease Clin. Ther. 28 1983 1988 17296455 10.1016/j.clinthera.2006.12.012 1:CAS:528: DC%2BD2sXhvVWktr8%3D (Pubitemid 46215747)
11. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2007 A metaanalysis of antibiotic therapy for active ulcerative colitis Dig. Dis. Sci. 52 2920 2925 17415632 10.1007/s10620-007-9760-1 1:CAS:528:DC%2BD2sXhtFSlsrvL (Pubitemid 47512546)
12. D.E. Baker 2005 Rifaximin: a nonabsorbed oral antibiotic Rev. Gastroenterol. Disord. 5 19 30 15741929
13. J.B. Ewaschuk Q.Z. Tejpar I. Soo K. Madsen R.N. Fedorak 2006 The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease Curr. Gastroenterol. Rep. 8 486 498 17105688 10.1007/s11894-006-0039-z (Pubitemid 46017161)
14. P. Gionchetti F. Rizzello K.M. Lammers C. Morselli L. Sollazzi S. Davies, et al. 2006 Antibiotics and probiotics in treatment of inflammatory bowel disease World J. Gastroenterol. 12 3306 3313 16733845 1:CAS:528: DC%2BD28XnsFWkt78%3D (Pubitemid 43933773)
15. P. Gionchetti F. Rizzello A. Venturi F. Ugolini M. Rossi P. Brigidi, et al. 1999 Antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach Eur. Rev. Med. Pharmacol. Sci. 3 27 30 10710827 1:STN:280:DC%2BD3c7ns1WlsA%3D%3D
16. D.B. Sachar 1998 How do you treat refractory pouchitis and when do you decide to remove the pouch? Inflamm. Bowel Dis. 4 165 166 9589302 10.1002/ibd.3780040212 1:STN:280:DyaK1c3ltFajtQ%3D%3D
17. W.J. Sandborn R. McLeod D.P. Jewell 1999 Medical therapy for induction and maintenance of remission in pouchitis: a systematic review Inflamm. Bowel Dis. 5 33 39 10028447 1:STN:280:DyaK1M7lt1yjsw%3D%3D
18. M.V. Madden A.S. McIntyre R.J. Nicholls 1994 Doubleblind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis Dig. Dis. Sci. 39 1193 1196 8200250 10.1007/BF02093783 1:STN:280:ByuB2MfpsFQ%3D (Pubitemid 24190255)
19. A. Sambuelli L. Boerr S. Negreira A. Gil G. Camartino S. Huernos, et al. 2002 Budesonide enema in pouchitis-a double-blind, double-dummy, controlled trial Aliment. Pharmacol. Ther. 16 27 34 11856075 10.1046/j.1365-2036.2002. 01139.x 1:CAS:528:DC%2BD38XhvFGlsLY%3D (Pubitemid 34123861)
20. B. Shen V. Fazio F. Remzi A. Bennett R. Lopez A. Brzezinski, et al. 2007 Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis Dis. Col. Rectum. 50 498 508 10.1007/s10350-006-0828-3 (Pubitemid 46701616)
21. K.L. Isaacs R.S. Sandler M. Abreu M.F. Picco S.B. Hanauer S.J. Bickston, et al. 2007 Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study Inflamm. Bowel Dis. 13 1250 1255 17567869 10.1002/ibd.20187 (Pubitemid 47597772)
22. B. Shen J.P. Achkar B.A. Lashner A.H. Ormsby F.H. Remzi A. Brzezinski, et al. 2001 A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis Inflamm. Bowel Dis. 7 301 305 11720319 10.1097/00054725-200111000-00004 1:STN:280:DC%2BD3MnnsVeltQ%3D%3D
23. K. Nygaard T. Bergan A. Bjorneklett T. Hoverstad J. Lassen S. Aase 1994 Topical metronidazole treatment in pouchitis Scand. J. Gastroenterol. 29 462 467 8036463 10.3109/00365529409096839 1:STN:280:ByuA3M%2FktVc%3D
24. M. Egger G.D. Smith A.N. Phillips 1997 Meta-analysis: principles and procedures B. M. J. 315 1533 1537 1:STN:280:DyaK1c%2Fpt1Slsg%3D%3D
25. A.S. Abdelrazeq S.M. Kelly J.N. Lund S.H. Leveson 2005 Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis Colorectal Dis. 7 182 186 15720360 10.1111/j.1463-1318. 2004.00746.x 1:STN:280:DC%2BD2M%2FptFansg%3D%3D (Pubitemid 40352650)
26. V. Abitbol S. Chaussade 1997 Pouchitis after ileal pouchanal anastomosis Gastroenterol. Clin. Biol. 21 299 304 9207998 1:STN:280:ByiA2M7ntFI%3D
27. J.M. Becker A.F. Stucchi D.E. Bryant 1998 How do you treat refractory pouchitis and when do you decide to remove the pouch? Inflamm. Bowel Dis. 4 167 169 9589303 10.1002/ibd.3780040213 1:STN:280:DyaK1c3ltFajug%3D%3D
28. L. Gerard K.W. Garey H.L. DuPont 2005 Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections Expert. Rev. Anti. Infect. Ther. 3 201 211 15918778 10.1586/14787210.3.2.201 1:CAS:528:DC%2BD2MXjt1ymu7w%3D (Pubitemid 40590326)
29. P. Gionchetti C. Amadini F. Rizzello A. Venturi G. Poggioli M. Campieri 2003 Diagnosis and treatment of pouchitis Best Pract. Res. Clin. Gastroenterol. 17 75 87 12617884 10.1053/bega.2002.0348
30. T. Mimura F. Rizzello U. Helwig G. Poggioli S. Schreiber I.C. Talbot, et al. 2002 Four-week openlabel trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis Aliment. Pharmacol. Ther. 16 909 917 11966499 10.1046/j.1365-2036.2002.01203.x 1:CAS:528:DC%2BD38Xkt1Gksbo%3D (Pubitemid 34461760)
31. T.E. Madiba D.C. Bartolo 2001 Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome J. R. Coll. Surg. Edinb. 46 334 337 11768572 1:STN:280:DC%2BD38%2Fkt1Snsw%3D%3D
32. P. Gionchetti F. Rizzello A. Venturi F. Ugolini M. Rossi P. Brigidi, et al. 1999 Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis Aliment. Pharmacol. Ther. 13 713 718 10383499 10.1046/j.1365-2036.1999.00553.x 1:CAS:528:DyaK1MXksVartrk%3D (Pubitemid 29276839)
33. B. Shen F.H. Remzi A.R. Lopez E. Queener 2008 Rifaximin for maintenance therapy in antibioticdependent pouchitis BMC Gastroenterol. 23 26 10.1186/1471-230X-8-26 (Pubitemid 351998102)
34. P. Gionchetti F. Rizzello U. Helwig A. Venturi K.M. Lammers P. Brigidi, et al. 2003 Prophylaxis of pouchitis onset with probiotic therapy: a doubleblind, placebo-controlled trial Gastroenterology 124 1202 1209 12730861 10.1016/S0016-5085(03)00171-9 (Pubitemid 36531796)
35. B. Elahi S. Nikfar S. Derakhshani M. Vafaie M. Abdollahi 2007 Benefit of probiotics in the control of pouchitis in patients underwent ileal pouch anal anastomosis operation; A meta-analysis of controlled clinical trials Dig. Dis. Sci. 53 1278 1284 17940902 10.1007/s10620-007-0006-z
36. A. Sambuelli L. Boerr S. Negreira A. Gil G. Camartino S. Huernos, et al. 2002 Budesonide enema in pouchitis-a double-blind, double-dummy, controlled trial Aliment. Pharmacol. Ther. 16 27 34 11856075 10.1046/j.1365-2036.2002. 01139.x 1:CAS:528:DC%2BD38XhvFGlsLY%3D (Pubitemid 34123861)
37. P. Gionchetti F. Rizzello A. Venturi M. Ferretti C. Brignola S. Peruzzo, et al. 1997 Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis Aliment. Pharmacol. Ther. 11 673 678 9305474 10.1046/j.1365-2036.1997.00217.x 1:CAS:528:DyaK2sXmtl2iurw%3D
38. P. Wischmeyer J.H. Pemberton S.F. Phillips 1993 Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study Mayo Clin. Proc. 68 978 981 8412364 1:STN:280:ByuD3Mfgt1U%3D
39. K.E. Levin J.H. Pemberton S.F. Phillips A.R. Zinsmeister M.E. Pezim 1992 Role of oxygen free radicals in the etiology of pouchitis Dis. Colon Rectum 35 452 456 1568395 10.1007/BF02049401 1:STN:280:By2B3szns1U%3D
40. R.D. Hurst M. Molinari T.P. Chung M. Rubin F. Michelassi 1996 Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy Arch. Surg. 131 497 500 8624195 1:STN:280:BymB3cfpvFw%3D
41. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2008 A metaanalysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for prevention of disease relapse and maintenance of remission Arch. Med. Sci. 4 185 190
42. R. Rahimi S. Nikfar F. Rahimi B. Elahi S. Derakhshani M. Vafaie, et al. 2008 A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease Dig. Dis. Sci. 53 2524 2531 18270836 10.1007/s10620-007-0171-0
43. S. Nikfar R. Rahimi F. Rahimi S. Derakhshani M. Abdollahi 2008 Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials Dis. Col. Rectum 51 1775 1780 10.1007/s10350-008-9335-z
44. P. Fric 2007 Probiotics and prebiotics; resistance of a therapeutic principle Cent. Eur. J. Med. 2 237 270 10.2478/s11536-007-0031-5 (Pubitemid 47025076)
45. R. Rahimi S. Nikfar M. Abdollahi 2008 Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials Arch. Med. Sci. 4 71 76 1:CAS:528: DC%2BD1cXosVams7g%3D
46. N.J. Talley 2008 Newer antidepressants in irritable bowel syndrome: what is the evidence? Arch. Med. Sci. 4 77 78
47. R. Rahimi S. Nikfar M. Abdollahi 2007 Meta-analysis technique confirms the effectiveness of anti-TNF-a in the management of active ulcerative colitis when administered in combination with corticosteroids Med. Sci. Monit. 13 PI13 PI18 17599035 1:CAS:528:DC%2BD2sXpt1aqsr0%3D
48. R. Rahimi S. Nikfar M. Abdollahi 2007 Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials Biomed. Pharmacother. 61 75 80 17184965 10.1016/j.biopha.2006.06.022 1:CAS:528:DC%2BD2sXht1Olsb4%3D (Pubitemid 46185874)
49. A. Hosseini-Tabatabaei M. Abdollahi 2008 Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel disease? Inflamm. Allergy Drug Targets 7 129 135 18782019 10.2174/187152808785748164 1:CAS:528:DC%2BD1cXhtFCrtLvJ
50. A. Rezaie R.D. Parker M. Abdollahi 2007 Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci. 52 2015 2021 17404859 10.1007/s10620-006-9622-2 (Pubitemid 47246507)